Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
View Scopus Profile
Peili ZHU, Dr
Research Assistant Professor
,
Chinese Medicine - Teaching and Research Division
https://orcid.org/0000-0003-2586-7156
Email
pellyzhu
hkbu.edu
hk
2019
2025
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(3)
Research Output
(33)
Activities
(3)
Similar Scholars
(3)
Supervised Work
(3)
Fingerprint
Dive into the research topics where Peili ZHU is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Anti-melanoma
53%
Autophagy
48%
Signal Transducer and Activator of Transcription 3
43%
Apoptosis
40%
Melanoma Cells
36%
STAT3 Signaling
35%
Schisandra chinensis
32%
Glycogen Synthase Kinase 3 (GSK3)
28%
Melanoma
25%
Protein Level
24%
Mouse Model
24%
China
24%
Alzheimer's Disease
23%
Induced Apoptosis
22%
Lonicerae Japonicae Flos
22%
PI3K-AKT-mTOR Signaling
21%
Colorectal Cancer Cells
21%
Protective Autophagy
20%
Sophorae Flos
20%
Isoalantolactone
20%
Heme oxygenase-1 (HO-1)
20%
Oleanolic Acid
20%
Hippocampal Neurogenesis
20%
Ethanol Extract
16%
RAW264.7 Macrophages
16%
Mechanism of Action
15%
Cell Cycle Arrest
14%
Cancer Effects
13%
Mammalian Target of Rapamycin (mTOR)
13%
Traditional Chinese Medicine
12%
Cognitive Deficits
12%
NF-B
12%
Herbal Formula
12%
Protective Effect
11%
Network Pharmacology
11%
Serum Triglycerides
11%
Tumor Growth
11%
APPPS1
11%
Neural Stem Cells
11%
Signaling Pathway
10%
Antimetastatic Effect
10%
Wound Healing
10%
Melanoma Progression
10%
Melanoma Microenvironment
10%
Osteoclastogenesis
10%
STAT3 Signaling Pathway
10%
Splenocytes
10%
Herb Formula
10%
Immune Molecules
10%
Collagen-induced Arthritis Rat
10%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
STAT3 Protein
39%
Traditional Chinese Medicine
33%
Mouse Model
25%
Alzheimer's Disease
24%
Lonicera
22%
Colorectal Carcinoma
21%
Systemic Lupus Erythematosus
20%
Oleanolic Acid
20%
Cognitive Defect
20%
Schisandra chinensis
19%
Inflammation
15%
Western Blot
14%
Triacylglycerol
13%
Glycogen Synthase Kinase
12%
Reactive Oxygen Metabolite
12%
Network Pharmacology
11%
Wound Healing
11%
Catenin
11%
Malignant Neoplasm
11%
Protein Kinase B
11%
Antioxidant
11%
Diseases
10%
Tumor Necrosis Factor
10%
Momordica charantia
10%
Edible Plant
10%
Ribosome Inactivating Protein
10%
Styrofoam
10%
Liver Cancer
10%
Reperfusion Injury
10%
Liver Cell Carcinoma
10%
Lipoprotein
10%
Heme Oxygenase 1
10%
Parkinson's Disease
10%
Toll Like Receptor 4
10%
Protopanaxadiol
10%
Luteolin
10%
Schisandra
10%
Autoimmune Hepatitis
10%
Gamma Chemokine
10%
Intestine Flora
10%
Chemokine Receptor
10%
Brain Ischemia
10%
Astragalus Root
10%
Gomisin
10%
Toxic Hepatitis
10%
Glycogen Synthase Kinase 3
10%
Hepatomegaly
10%
Transgenic Mouse
10%
Thearubigins
10%
Medicine and Dentistry
Melanoma
74%
Melanoma Cell
40%
Autophagy
33%
In Vitro
30%
Programmed Cell Death
29%
STAT3 Protein
27%
Mammalian Target of Rapamycin
18%
Macrophage
15%
Traditional Chinese Medicine
13%
Osteoclastogenesis
10%
Systemic Lupus Erythematosus
10%
Immunocompetent Cell
10%
DNA Damage
10%
Ginsenoside Rh 2
10%
Gomisin
10%
Toll Like Receptor 4
10%
Ubiquitination
10%
extracellular signal regulated kinase
10%
Lipopolysaccharide
10%
Luteolin
10%
Liver Cancer
10%
Complementary and Alternative Medicine
10%
Inflammatory Mediator
10%
Immunoglobulin Enhancer Binding Protein
10%
Cell Cycle Arrest
9%
Cell Cycle Checkpoint
9%
Osteoclast
8%
Collagen-Induced Arthritis
8%
Docking (Molecular)
7%
Protein Kinase B
7%
Nuclear Factor
6%
Alternative Complement Pathway C3 C5 Convertase
6%
Osteoclast Differentiation Factor
6%
COVID-19
6%
Cell Viability
6%
mTOR Signaling
6%
Allograft
6%
Prostaglandin E2
6%
Nitric Oxide
6%
Tumor Progression
5%
Neoplasm
5%
Inflammatory Disorder
5%
Messenger RNA
5%
Western Blot
5%
Immunosuppressive Drug
5%
Malignant Neoplasm
5%
Flow Cytometry
5%
Immunoblotting
5%
